Evidence map›Paper›PMID 39100579›Full record

ArticleStructural heart : the journal of the Heart Team2024

Predictors and Trends of New Permanent Pacemaker Implantation: A Subanalysis of the International Navitor IDE Study.

Ibrahim Sultan, Michael J Reardon, Lars Søndergaard, Bassem Chehab, Dave Smith, Antony S Walton, Stephen G Worthley, Ganesh Manoharan, Gerald Yong, Hasan Jilaihawi and 3 more

Abstract read
In one paragraph

Article in Structural heart : the journal of the Heart Team, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Pacemaker Implantation Rates With the Self-Expandable Navitor Valve.Journal of the American Heart Association · 2026
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ibrahim SultanDivision of Cardiac Surgery, Department of Cardiothoracic Surgery, Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Michael J ReardonDepartment of Cardiovascular Surgery, Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas, USA.
Lars SøndergaardStructural Heart Medical Affairs, Abbott Medical, Santa Clara, California, USA.
Bassem ChehabDepartment of Cardiology, Ascension Via Christi Hospital, University of Kansas, Wichita, Kansas, USA.
Dave SmithMorriston Hospital, Swansea Bay University Health Board, Swansea, UK.
Antony S WaltonDepartment of Interventional Cardiology, Alfred Hospital, Melbourne, Victoria, Australia.
Stephen G WorthleyDepartment of Cardiology, Macquarie University Hospital, Macquarie Park, New South Wales, Australia.
Ganesh ManoharanRegional Cardiology Centre, Royal Victoria Hospital, Belfast, UK.
Gerald YongDepartment of Cardiology, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.
Hasan JilaihawiDepartment of Cardiology, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Federico AschCardiovascular Core Labs, MedStar Health Research Institute and Georgetown University, Washington, District of Columbia, USA.
Nicholas BatesStructural Heart Clinical Affairs, Abbott Medical, St. Paul, Minnesota, USA.
Gregory P FontanaCardiovascular Institute, Hospital Corporation of America, Los Robles Regional Medical Center, Thousand Oaks, California, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The Navitor Investigational Device Exemption (IDE) study is a prospective, multicenter, global study assessing the safety and effectiveness of the Navitor valve in a population with severe, symptomatic aortic stenosis who are at high and extreme surgical risk. The impact of pre-existing conduction abnormalities and implantation technique on new permanent pacemaker implantation (PPI) for the Navitor platform is not fully understood. Therefore, the goal of this analysis was to investigate the associations between patient and procedural factors and the 30-day new PPI rate. Methods: A total of 260 patients who underwent implantation of a Navitor valve in the Navitor IDE study were reviewed. Patients with preprocedural permanent pacemakers (n = 28) were excluded. Baseline risk factors were assessed for statistical significance. Multivariable logistic regression analyses were performed to identify independent predictors of new PPI. Results: Mean age of the pacemaker-naïve population was 83.3 ± 5.2 years, 58.6% were female, average Society of Thoracic Surgeons score was 3.8% ± 1.9%, median frailty score was 1 (interquartile range 1, 2), and 17.7% were deemed at extreme surgical risk. Pre-existing first-degree atrioventricular block and right bundle branch block significantly increased the risk of new PPI postimplantation, whereas left bundle branch block did not. Membranous septum length in relation to noncoronary cusp implant depth was a significant predictor of new PPI, with higher rates of new PPI observed when noncoronary cusp implant depth exceeded membranous septum length. Analysis of implant depth alone revealed deeper implants were associated with a higher rate of new PPI, regardless of patient baseline conduction abnormality. Conclusions: The 30-day rate of new PPI in the Navitor IDE study is associated with patient pre-existing baseline conduction disturbances and implantation depth.

Indexed as

Aortic stenosisConduction abnormalityNavitorPacemakerTranscatheter aortic valve implantationTranscatheter aortic valve replacement

Identifiers

PMID39100579
PMCPMC11294828

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.